Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Graterol, Fredzzia ^a   Navarro Muñoz, Maribel ^a   Ibernon, Meritxell ^a   López, Dolores ^a   Troya, Maria Isabel ^a   Pérez, Vanessa ^a   Bonet, Josep ^a   Romero, Ramón ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BETA 2 MICROGLOBULIN; BRADYKININ; COMPLEMENT COMPONENT C4; CREATININE; PEPTIDE; PLASMA PROTEIN; TAMM HORSFALL GLYCOPROTEIN; BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY INJURY; MALE; PEPTIDE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEOMICS; URINALYSIS; BLOOD; GLOMERULONEPHRITIS, IGA; KIDNEY FUNCTION TEST; MASS SPECTROMETRY; MIDDLE AGED; PROCEDURES; URINE;

ADULT; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; URINALYSIS;

EID: 84875946167     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-82     Document Type: Article

References (45)

1. IgA nephropathy. Barratt J, Feehally J, J Am Soc Nephrol 2005 16 7 2088 2097 10.1681/ASN.2005020134 15930092
2. IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Nephrologues de l'Est. Frimat L, Briancon S, Hestin D, Aymard B, Renoult E, Huu TC, Kessler M, Nephrol Dial Transplant 1997 12 12 2569 2575 10.1093/ndt/12.12.2569 9430853
3. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. D'Amico G, Am J Kidney Dis 2000 36 2 227 237 10.1053/ajkd.2000.8966 10922300
4. Tubular lesions determine prognosis of IgA nephropathy. Daniel L, Saingra Y, Giorgi R, Bouvier C, Pellissier JF, Berland Y, Am J Kidney Dis 2000 35 1 13 20 10.1016/S0272-6386(00)70295-2 10620538
5. Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy. Myllymaki JM, Honkanen TT, Syrjanen JT, Helin HJ, Rantala IS, Pasternack AI, Mustonen JT, Kidney Int 2007 71 4 343 348 10.1038/sj.ki.5002046 17191083
6. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H, Kidney Int 2009 76 5 534 545 10.1038/ki.2009.243 19571791
7. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H, Kidney Int 2009 76 5 546 556 10.1038/ki.2009.168 19571790
8. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator SN, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo AB, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H, Kidney Int 2010 77 10 921 927 10.1038/ki.2010.43 20200498
9. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Kang SH, Choi SR, Park HS, Lee JY, Sun IO, Hwang HS, Chung BH, Park CW, Yang CW, Kim YS, Choi YJ, Choi BS, Nephrol Dial Transplant 2012 27 1 252 258 10.1093/ndt/gfr295 21606384
10. Biomarker discovery in glomerular diseases using urinary proteomics. Thongboonkerd V, Proteomics Clin Appl 2008 2 10-11 1413 1421 21136790
11. Urinary proteomics and biomarker discovery for glomerular diseases. Thongboonkerd V, Klein JB, Jevans AW, McLeish KR, Contrib Nephrol 2004 141 292 307 14650240
12. Renal and Urinary Proteomics. Thongboonkerd V, Proteomics Clin Appl 2008 2 7-8 947 949 21136895
13. Biomarker discovery for kidney diseases by mass spectrometry. Niwa T, J Chromatogr B Analyt Technol Biomed Life Sci 2008 870 2 148 153 10.1016/j.jchromb.2007.10.035 18024247
14. Urine proteomics: the present and future of measuring urinary protein components in disease. Barratt J, Topham P, CMAJ 2007 177 4 361 368 17698825
15. Human urine proteomics: building a list of human urine cancer biomarkers. Casado-Vela J, del Pulgar TG, Cebrian A, Alvarez-Ayerza N, Lacal JC, Expert Rev Proteomics 2011 8 3 347 360 10.1586/epr.11.26 21679116
16. Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Park MR, Wang EH, Jin DC, Cha JH, Lee KH, Yang CW, Kang CS, Choi YJ, Proteomics 2006 6 3 1066 1076 10.1002/pmic.200500023 16372274
17. Proteomics in renal research. Janech MG, Raymond JR, Arthur JM, Am J Physiol Renal Physiol 2007 292 2 501 F512 17107941
18. Biomarker discovery in urine by proteomics. Pang JX, Ginanni N, Dongre AR, Hefta SA, Opitek GJ, J Proteome Res 2002 1 2 161 169 10.1021/pr015518w 12643536
19. Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, Del Boccio P, Pavone B, Perfumo F, Urbani A, Scolari F, Ghiggeri GM, J Am Soc Nephrol 2006 17 11 3139 3148 10.1681/ASN.2006050486 17005933
20. Very low-molecular-mass fragments of albumin in the plasma of patients with focal segmental glomerulosclerosis. Hellin JL, Bech-Serra JJ, Moctezuma EL, Chocron S, Santin S, Madrid A, Vilalta R, Canals F, Torra R, Meseguer A, Nieto JL, Am J Kidney Dis 2009 54 5 871 880 10.1053/j.ajkd.2009.07.011 19781833
21. Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin. Magistroni R, Ligabue G, Lupo V, Furci L, Leonelli M, Manganelli L, Masellis M, Gatti V, Cavazzini F, Tizzanini W, Albertazzi A, Nephrol Dial Transplant 2009 24 5 1672 1681 10.1093/ndt/gfp020 19211645
22. Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery. Ngai HH, Sit WH, Jiang PP, Xu RJ, Wan JM, Thongboonkerd V, J Proteome Res 2006 5 11 3038 3047 10.1021/pr060122b 17081055
23. Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Rocchetti MT, Centra M, Papale M, Bortone G, Palermo C, Centonze D, Ranieri E, Di Paolo S, Gesualdo L, Proteomics 2008 8 1 206 216 10.1002/pmic.200700492 18095357
24. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis. Shui HA, Huang TH, Ka SM, Chen PH, Lin YF, Chen A, Nephrol Dial Transplant 2008 23 1 176 185 17881425
25. Urine biomarkers predict the cause of glomerular disease. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM, J Am Soc Nephrol 2007 18 3 913 922 10.1681/ASN.2006070767 17301191
26. Absence of increased alpha1-microglobulin in IgA nephropathy proteinuria. Yokota H, Hiramoto M, Okada H, Kanno Y, Yuri M, Morita S, Naitou M, Ichikawa A, Katoh M, Suzuki H, Mol Cell Proteomics 2007 6 4 738 744 10.1074/mcp.M600336- MCP200 17242005
27. Biomarker discovery with SELDI-TOF MS in human urine associated with early renal injury: evaluation with computational analytical tools. Vanhoutte KJ, Laarakkers C, Marchiori E, Pickkers P, Wetzels JF, Willems JL, van den Heuvel LP, Russel FG, Masereeuw R, Nephrol Dial Transplant 2007 22 10 2932 2943 10.1093/ndt/gfm170 17616539
28. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H, Kidney Int 2005 67 6 2313 2320 10.1111/j.1523-1755. 2005.00335.x 15882273
29. Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases. Julian BA, Wittke S, Haubitz M, Zurbig P, Schiffer E, McGuire BM, Wyatt RJ, Novak J, World J Urol 2007 25 5 467 476 10.1007/s00345-007-0192-5 17619884
30. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Weissinger EM, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R, Golovko I, Rupprecht HD, Haubitz M, Hecker H, Mischak H, Fliser D, Kidney Int 2004 65 6 2426 2434 10.1111/j.1523-1755.2004.00659.x 15149356
31. Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. Xu BJ, Shyr Y, Liang X, Ma LJ, Donnert EM, Roberts JD, Zhang X, Kon V, Brown NJ, Caprioli RM, Fogo AB, J Am Soc Nephrol 2005 16 10 2967 2975 10.1681/ASN.2005030262 16079267
32. Urinary proteomics in diabetes and CKD. Rossing K, Mischak H, Dakna M, Zurbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P, J Am Soc Nephrol 2008 19 7 1283 1290 10.1681/ASN.2007091025 18448586
33. Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy. Papale M, Di Paolo S, Magistroni R, Lamacchia O, Di Palma AM, De Mattia A, Rocchetti MT, Furci L, Pasquali S, De Cosmo S, Cignarelli M, Gesualdo L, Diabetes Care 2010 33 11 2409 2415 10.2337/dc10-0345 20671095
34. Urinary peptides as a diagnostic tool for renal failure detected by matrix-assisted laser desorption/ionisation mass spectrometry: an evaluation of their clinical significance. Lapolla A, Molin L, Seraglia R, Sechi A, Cosma C, Bonfante L, Chilelli NC, Ragazzi E, Traldi P, Eur J Mass Spectrom (Chichester, Eng) 2011 17 3 245 253 10.1255/ejms.1124
35. Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study. Lapolla A, Seraglia R, Molin L, Williams K, Cosma C, Reitano R, Sechi A, Ragazzi E, Traldi P, J Mass Spectrom 2009 44 3 419 425 10.1002/jms.1520 19165811
36. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, Ceglarek U, Clin Chem 2007 53 3 421 428 10.1373/clinchem.2006.077834 17272489
37. Identification of a uromodulin fragment for diagnosis of IgA nephropathy. Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K, Chen X, Rapid Commun Mass Spectrom 2010 24 14 1971 1978 10.1002/rcm.4601 20552702
38. Uromodulin and alpha(1)-Antitrypsin Urinary Peptide Analysis to Differentiate Glomerular Kidney Diseases. Navarro-Munoz M, Ibernon M, Bonet J, Perez V, Pastor MC, Bayes B, Casado-Vela J, Navarro M, Ara J, Espinal A, Fluvia L, Serra A, Lopez D, Romero R, Kidney Blood Press Res 2012 35 5 314 325 10.1159/000335383 22399069
39. Proteomic approach to the study of statin pleiotropy in kidney transplant patients. Perez V, Navarro-Munoz M, Mas S, Bayes B, Pastor MC, Martinez-Caceres E, Lauzurica R, Egido J, Romero R, Pharmacology 2011 87 3-4 161 168 21372619
40. Proteomic analysis of alpha-1-antitrypsin in immunoglobulin A nephropathy. Kwak NJ, Wang EH, Heo IY, Jin DC, Cha JH, Lee KH, Yang CW, Kang CS, Choi YJ, Proteomics Clin Appl 2007 1 4 420 428 10.1002/prca.200600288 21136694
41. Evidence for a role of uromodulin in chronic kidney disease progression. Prajczer S, Heidenreich U, Pfaller W, Kotanko P, Lhotta K, Jennings P, Nephrol Dial Transplant 2010 25 6 1896 1903 10.1093/ndt/gfp748 20075439
42. Uromodulin and chronic kidney disease. Lhotta K, Kidney Blood Press Res 2010 33 5 393 398 10.1159/000320681 20948228
43. Uromodulin biology and pathophysiology-an update. Vyletal P, Bleyer AJ, Kmoch S, Kidney Blood Press Res 2010 33 6 456 475 10.1159/000321013 21109754
44. The kallikrein-kinin system in diabetic nephropathy. Tomita H, Sanford RB, Smithies O, Kakoki M, Kidney Int 2012 81 8 733 744 10.1038/ki.2011.499 22318421
45. Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis. Pereira RL, Buscariollo BN, Correa-Costa M, Semedo P, Oliveira CD, Reis VO, Maquigussa E, Araujo RC, Braga TT, Soares MF, Moura IC, Malheiros DM, Filho AP, Keller AC, Camara NO, Kidney Int 2011 79 11 1217 1227 10.1038/ki.2011.14 21412216